dc.contributor.author | Allison, Robert D | |
dc.date.accessioned | 2022-08-26T18:05:59Z | |
dc.date.available | 2022-08-26T18:05:59Z | |
dc.date.issued | 2016-06 | |
dc.identifier.uri | https://clinicaltrials.gov/ct2/show/NCT02794181 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/2815 | |
dc.description.abstract | The primary aims of this study are to: 1) assess the prevalence of ZIKV, DENV and CHIKV infection (RNA-positives) among adults who attempted to donate blood but were deferred because of travel to places with local transmission of ZIKV, DENV and/or CHIKV (travel-deferred donors); 2) assess the prevalence of ZIKV infection (RNA-positives) among adults who attempted to donate blood who were deferred due to potential sexual exposure to ZIKV infection; 3) assess the prevalence of ZIKV, DENV and CHIKV infection (RNA-positives) among blood donors whose blood or platelets were collected and who called back to report any illness within 2 weeks of donation; and to 4) study the 24-week natural history of ZIKV, DENV and CHIKV infection among deferred adult donors who tested RNA-positive for any of these agents. | en_US |
dc.language | English | en_US |
dc.subject | Zika Research Project | en_US |
dc.subject | Zika Virus | en_US |
dc.subject | Chikungunya | en_US |
dc.subject | Dengue | en_US |
dc.title | Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD) | en_US |
eihealth.country | Others | en_US |
eihealth.category | Epidemiology and epidemiological studies | en_US |
eihealth.type | Research protocol information | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.contributor.corporatename | United States of America. National Institutes of Health Clinical Center | en_US |